Home › Calculator › DSKYF Dividend Calculator 2026
DSKYF Dividend DRIP Calculator 2026
2.83% YieldHealthcareDaiichi Sankyo Company, Limited · OTC
Price: $18.00 · Annual div: $0.51/share · Frequency: quarterly · Payout ratio: 50% · Ex-div: TBD
Calculator settings
Portfolio growth: DRIP vs No DRIP
Annual dividend income growth
💡 What-if scenarios
Click to apply scenario to the calculator
🎯 When DSKYF pays your bills
Year your monthly dividend income covers each expense (based on current settings)
Share your DSKYF snowball 📈
$10,000 in DSKYF → $13.53M in 10 years · $30,998.82/month
About Daiichi Sankyo Company, Limited (DSKYF) — Dividend Analysis 2026
Daiichi Sankyo Company, Limited operates as a global pharmaceutical powerhouse, dedicated to the research, development, manufacturing, and worldwide commercialization of a wide array of medicinal products. The company boasts an extensive portfolio of therapeutics spanning numerous health conditions. In oncology, its offerings include trastuzumab deruxtecan, an innovative anti-HER2 antibody-drug conjugate for cancer treatment, alongside agents such as gefitinib for malignant tumors, bicalutamide for prostate cancer, and tamoxifen for breast cancer. For chronic diseases, Daiichi Sankyo provides mirogabalin for pain management; treatments for type 2 diabetes mellitus like teneligliptin/canagliflozin and teneligliptin; and medications for hypercholesterolemia, including pravastatin and colesevelam (which also addresses type 2 diabetes). Bone health is supported by denosumab for osteoporosis and related conditions, while anemia is managed with ferric carboxymaltose and iron sucrose injections. Its cardiovascular and neurological solutions include the antiplatelet agent prasugrel, the anticoagulant edoxaban, and the antihypertensive olmesartan; as well as lacosamide for epilepsy and memantine for Alzheimer's disease. Other key prescription products address conditions such as ulcers (esomeprazole), influenza (laninamivir), bacterial infections (levofloxacin), dysuria (silodosin), and general pain and inflammation (loxoprofen). Beyond prescription drugs, Daiichi Sankyo also markets a selection of consumer health items. These comprise the multi-symptom cold remedy Lulu, the antipyretic/anti-inflammatory pain reliever Loxonin S, Transino for skin discoloration like melasma and freckles, Minon skincare products, and the oral hygiene brands Breath Labo and Clean Dental. Furthermore, the company produces various vaccines, including those for influenza (both cell culture-derived and HA types), measles, rubella, and mumps. Its diverse operations extend to veterinary pharmaceuticals, cosmetics, medical equipment, food products, drinking water, and the production of active pharmaceutical ingredients (APIs) and chemical intermediates. A significant collaboration involves Guardant Health, with whom Daiichi Sankyo is developing Guardant360 CDx as a companion diagnostic for Enhertu, specifically targeting advanced metastatic non-small cell lung cancer. Established in 1899, this long-standing organization is headquartered in Tokyo, Japan.
Compare DSKYF with similar stocks
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
Get Your Full DSKYF DRIP Report by Email
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. · Privacy Policy
Ready to invest? Open DSKYF position with:
🌍 DSKYF Yield by Country & Account Type
Real after-tax yield depends on where you live and how you hold DSKYF.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| 🇺🇸 Roth IRA / 401k | 0% | 2.83% | 0.03% | $283 / yr |
| 🇺🇸 US Taxable (15%) ✓ | 15% | 2.41% | -0.39% | $241 / yr |
| 🇺🇸 US Taxable (20%) | 20% | 2.26% | -0.54% | $226 / yr |
| 🇬🇧 UK ISA | 0% | 2.83% | 0.03% | $283 / yr |
| 🇬🇧 UK Taxable | 8.75% | 2.58% | -0.22% | $258 / yr |
| 🇨🇦 TFSA | 0% | 2.83% | 0.03% | $283 / yr |
| 🇨🇦 CA Taxable | 25% | 2.12% | -0.68% | $212 / yr |
| 🇦🇺 Super (pension) | 15% | 2.41% | -0.39% | $241 / yr |
| 🇦🇺 AU Taxable | 30% | 1.98% | -0.82% | $198 / yr |
| 🇩🇪 DE Taxable | 26.375% | 2.08% | -0.72% | $208 / yr |
| 🇫🇷 FR Taxable | 30% | 1.98% | -0.82% | $198 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
🎯 DSKYF Income Goal & Break-Even
12-month CPI (US BLS via FMP economic-indicators).
Based on current dividend of $0.51/share/yr · 🇺🇸 US Taxable (15%) · static projection (no growth assumed).
📅 DSKYF Dividend Payment Schedule
DSKYF pays quarterly — 4 times per year. Next ex-div: TBD.
📊 DSKYF vs Healthcare Benchmarks
How DSKYF compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024–2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for DSKYF sourced from FMP /financial-growth endpoint — real data, not estimates.
🏛️ DSKYF Insider Activity
No recent SEC filings reported in the last 90 days.Financial Health Scores
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores → lower dividend cut risk. Data via FMP financial statements.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the DSKYF dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer →
Daiichi Sankyo Company, Limited (DSKYF) is currently trading at $18.00, 57% below its 52-week high. The current dividend yield is 2.83% based on an annual payout of $0.51 per share.
DSKYF (Daiichi Sankyo Company, Limited) — 2.83% Dividend Yield Analysis
Daiichi Sankyo Company, Limited (DSKYF) is a healthcare stock currently trading at $18.00 with a dividend yield of 2.83%. The company pays an annual dividend of $0.51 per share. The payout ratio of 50% suggests the dividend is well-covered by earnings. Over the past 5 years, DSKYF has grown its dividend at a compound annual rate of 100.0%.
- Dividend payments are not guaranteed and can be reduced or suspended at any time.
Auto-generated from live market data. For educational purposes only — not financial advice.